There have been 50 recent insider transactions recorded for Incyte Corporation (INCY), including 16 buys and 33 sells. Total insider buying was valued at $8.39M and total insider selling at $37.61M.
Notable insiders with recent activity include Harrigan Edmund, Baker Bros. Advisors Lp, Clancy Paul J. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — INCY
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-31 |
Harrigan Edmund |
Director |
RSU Award |
269 |
$94.12 |
$25.32K |
21,122 |
| 2026-03-31 |
Baker Bros. Advisors Lp |
10 Percent Owner |
RSU Award |
421 |
- |
- |
2,818,039 |
| 2026-03-31 |
Clancy Paul J |
Director |
RSU Award |
265 |
$94.12 |
$24.94K |
23,741 |
| 2026-03-25 |
Trotta Matteo |
EVP, GM, Dermatology Us |
Tax Withholding of RSU |
537 |
$92.23 |
$49.53K |
14,882 |
| 2026-03-17 |
Cagnoni Pablo J |
President, R&d |
Option Exercise (Sell) |
7,166 |
$61.18 |
$438.42K |
9,102 |
| 2026-02-19 |
Cagnoni Pablo J |
President, R&d |
Option Exercise (Sell) |
13,093 |
$61.76 |
$808.62K |
7,182 |
| 2026-02-02 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Tax Withholding of RSU |
185 |
$102.67 |
$18.99K |
34,065 |
| 2026-02-02 |
Heeson Lee |
EVP, Head of Incyte Intl |
Tax Withholding of RSU |
111 |
$102.67 |
$11.4K |
38,041 |
| 2026-01-20 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Tax Withholding of RSU |
429 |
$102.62 |
$44.02K |
34,250 |
| 2026-01-16 |
Cagnoni Pablo J |
President, R&d |
RSU Award |
28,475 |
$106.21 |
$3.02M |
28,475 |
| 2026-01-16 |
Stein Steven H |
EVP & Chief Medical Officer |
RSU Award |
19,932 |
$106.21 |
$2.12M |
19,932 |
| 2026-01-16 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
RSU Award |
7,426 |
- |
- |
34,679 |
| 2026-01-16 |
Tray Thomas |
Principal Accounting Officer |
RSU Award |
2,425 |
$106.21 |
$257.56K |
2,425 |
| 2026-01-16 |
Trotta Matteo |
EVP, GM, Dermatology Us |
RSU Award |
8,542 |
$106.21 |
$907.25K |
8,542 |
| 2026-01-16 |
Heeson Lee |
EVP, Head of Incyte Intl |
RSU Award |
8,911 |
- |
- |
38,152 |
| 2026-01-16 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
RSU Award |
14,237 |
$106.21 |
$1.51M |
14,237 |
| 2026-01-16 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
RSU Award |
4,218 |
$106.21 |
$447.99K |
4,218 |
| 2026-01-07 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
Informative Sell |
10,856 |
$109.07 |
$1.18M |
66,132 |
| 2026-01-06 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
Tax Withholding of RSU |
8,264 |
$106.66 |
$881.44K |
76,988 |
| 2026-01-05 |
Stein Steven H |
EVP & Chief Medical Officer |
Informative Sell |
15,634 |
$101.70 |
$1.59M |
34,203 |
| 2025-12-31 |
Harrigan Edmund |
Director |
RSU Award |
245 |
$98.77 |
$24.2K |
20,853 |
| 2025-12-31 |
Baker Bros. Advisors Lp |
10 Percent Owner |
RSU Award |
328 |
- |
- |
2,817,618 |
| 2025-12-31 |
Clancy Paul J |
Director |
RSU Award |
241 |
$98.77 |
$23.8K |
23,476 |
| 2025-12-31 |
Stein Steven H |
EVP & Chief Medical Officer |
Tax Withholding of RSU |
13,292 |
$98.77 |
$1.31M |
49,837 |
| 2025-12-31 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Tax Withholding of RSU |
254 |
$98.77 |
$25.09K |
27,253 |
| 2025-12-19 |
Tray Thomas |
Principal Accounting Officer |
Option Exercise (Sell) |
1,044 |
$95.76 |
$99.97K |
- |
| 2025-12-18 |
Tray Thomas |
Principal Accounting Officer |
Informative Sell |
600 |
$98.25 |
$58.95K |
22,973 |
| 2025-12-17 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Informative Sell |
4,323 |
$97.26 |
$420.45K |
27,507 |
| 2025-12-16 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Informative Sell |
53,175 |
$97.29 |
$5.17M |
31,830 |
| 2025-12-11 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
Informative Sell |
255 |
$94.94 |
$24.21K |
60,011 |
| 2025-12-10 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
Informative Sell |
5,553 |
$95.58 |
$530.76K |
60,266 |
| 2025-12-08 |
Hoppenot Herve |
Director |
Tax Withholding of RSU |
2,843 |
$96.70 |
$274.92K |
326,803 |
| 2025-12-02 |
Stein Steven H |
EVP & Chief Medical Officer |
Informative Sell |
20,105 |
$102.51 |
$2.06M |
63,129 |
| 2025-12-01 |
Stein Steven H |
EVP & Chief Medical Officer |
Tax Withholding of RSU |
17,093 |
$102.04 |
$1.74M |
83,234 |
| 2025-12-01 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Tax Withholding of RSU |
326 |
$102.04 |
$33.27K |
85,838 |
| 2025-12-01 |
Hoffman Richard A. |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-12-01 |
Hoffman Richard A. |
EVP & General Counsel |
RSU Award |
9,466 |
- |
- |
9,466 |
| 2025-11-24 |
Tray Thomas |
Principal Accounting Officer |
Informative Sell |
600 |
$103.00 |
$61.8K |
23,573 |
| 2025-11-21 |
Tray Thomas |
Principal Accounting Officer |
Informative Sell |
169 |
$102.00 |
$17.24K |
24,173 |
| 2025-11-17 |
Denton Sheila A. |
EVP & General Counsel |
Option Exercise (Sell) |
278 |
$64.25 |
$17.86K |
8,883 |
| 2025-11-10 |
Hoppenot Herve |
Director |
Informative Sell |
187,500 |
$105.46 |
$19.77M |
329,646 |
| 2025-11-05 |
Stein Steven H |
EVP & Chief Medical Officer |
Option Exercise (Sell) |
1,194 |
$83.83 |
$100.09K |
- |
| 2025-11-04 |
Denton Sheila A. |
EVP & General Counsel |
Option Exercise (Sell) |
598 |
$58.06 |
$34.72K |
13,765 |
| 2025-11-03 |
Heeson Lee |
EVP, Head of Incyte Intl |
Informative Sell |
3,074 |
$94.02 |
$289.02K |
29,241 |
| 2025-10-15 |
Denton Sheila A. |
EVP & General Counsel |
Option Exercise (Sell) |
277 |
$64.25 |
$17.8K |
9,161 |
| 2025-10-03 |
Denton Sheila A. |
EVP & General Counsel |
Informative Sell |
3,501 |
$85.54 |
$299.48K |
26,569 |
| 2025-10-02 |
Denton Sheila A. |
EVP & General Counsel |
Option Exercise (Sell) |
599 |
$58.06 |
$34.78K |
14,363 |
| 2025-10-01 |
Heeson Lee |
EVP, Head of Incyte Intl |
Tax Withholding of RSU |
463 |
$86.70 |
$40.14K |
32,315 |
| 2025-10-01 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
Tax Withholding of RSU |
1,569 |
$86.70 |
$136.03K |
65,819 |
| 2025-09-30 |
Harrigan Edmund |
Director |
RSU Award |
289 |
$84.81 |
$24.51K |
20,608 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
